Note 15 - Segments (Tables)

3 Months Ended

Mar. 31, 2025

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	For the three months ended March 31,
(In thousands)	2025			2024
Revenue from services:
Pharmaceutical	$	—		$	—
Diagnostics		102,844			126,890
Corporate		—			—
	$	102,844		$	126,890
Revenue from products:
Pharmaceutical	$	34,842		$	38,047
Diagnostics		—			—
Corporate		—			—
	$	34,842		$	38,047
Revenue from transfer of intellectual property and other:
Pharmaceutical	$	12,266		$	8,749
Diagnostics		—			—
Corporate		—			—
	$	12,266		$	8,749
Cost of revenue:
Pharmaceutical	$	22,814		$	21,743
Diagnostics		84,518			109,874
Corporate		—			—
	$	107,332		$	131,617
Gross margin:
Pharmaceutical	$	24,294		$	25,053
Diagnostics		18,326			17,016
Corporate		—			—
	$	42,620		$	42,069
Selling, general and administrative:
Pharmaceutical	$	12,710		$	15,040
Diagnostics		37,956			45,761
Corporate		8,420			9,366
	$	59,086		$	70,167
Research and development:
Pharmaceutical	$	30,238		$	21,247
Diagnostics		538			665
Corporate		65			25
	$	30,841		$	21,937
Amortization of intangible assets:
Pharmaceutical	$	16,111		$	16,443
Diagnostics		3,750			4,994
Corporate		—			—
	$	19,861		$	21,437
Segment operating loss:
Pharmaceutical	$	(34,765	)	$	(27,677	)
Diagnostics		(23,918	)		(34,404	)
Corporate		(8,485	)		(9,391	)
	$	(67,168	)	$	(71,472	)

	For the three months ended March 31,
Depreciation and amortization:	2025		2024
Pharmaceutical	$	17,788	$	17,952
Diagnostics		5,699		7,868
Corporate		—		—
	$	23,487	$	25,820
Revenues:
United States	$	116,207	$	136,043
Ireland		5,480		9,222
Chile		14,532		14,889
Spain		6,439		5,659
Israel		73		160
Mexico		6,229		7,083
Other		992		630
	$	149,952	$	173,686

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	March 31,		December 31,
(In thousands)	2025		2024
Assets:
Pharmaceutical	$	1,336,076	$	1,359,270
Diagnostics		482,666		493,898
Corporate		309,585		347,044
	$	2,128,327	$	2,200,212
Goodwill:
Pharmaceutical	$	313,230	$	309,545
Diagnostics		163,442		219,707
	$	476,672	$	529,252